GREENLIGHT CAP.RE A DL-01 (G8L) - Total Liabilities
Based on the latest financial reports, GREENLIGHT CAP.RE A DL-01 (G8L) has total liabilities worth €1.53 Billion EUR (≈ $1.79 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of GREENLIGHT CAP.RE A DL-01 to track the company's year-over-year net asset growth rate.
GREENLIGHT CAP.RE A DL-01 - Total Liabilities Trend (2021–2025)
This chart illustrates how GREENLIGHT CAP.RE A DL-01's total liabilities have evolved over time, based on quarterly financial data. See GREENLIGHT CAP.RE A DL-01 (G8L) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
GREENLIGHT CAP.RE A DL-01 Competitors by Total Liabilities
The table below lists competitors of GREENLIGHT CAP.RE A DL-01 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bel Fuse A Inc
NASDAQ:BELFA
|
USA | $416.53 Million |
|
Zhejiang Xinneng Photovoltaic Technology Co Ltd
SHG:603105
|
China | CN¥2.37 Billion |
|
Sinoma Energy Conservation Ltd
SHG:603126
|
China | CN¥3.08 Billion |
|
UPC Technology Corp
TW:1313
|
Taiwan | NT$25.50 Billion |
|
Orthopediatrics Corp
NASDAQ:KIDS
|
USA | $163.48 Million |
|
Mistras Group Inc
NYSE:MG
|
USA | $339.07 Million |
|
Start Group
SHG:600734
|
China | CN¥1.20 Billion |
|
Wuhan Hiteck Biological Pharma Co Ltd
SHE:300683
|
China | CN¥393.09 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down GREENLIGHT CAP.RE A DL-01's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see G8L stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.67 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how GREENLIGHT CAP.RE A DL-01's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for GREENLIGHT CAP.RE A DL-01 (2021–2025)
The table below shows the annual total liabilities of GREENLIGHT CAP.RE A DL-01 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €1.46 Billion ≈ $1.71 Billion |
+5.90% |
| 2024-12-31 | €1.38 Billion ≈ $1.61 Billion |
+21.17% |
| 2023-12-31 | €1.14 Billion ≈ $1.33 Billion |
+5.75% |
| 2022-12-31 | €1.08 Billion ≈ $1.26 Billion |
+13.18% |
| 2021-12-31 | €951.83 Million ≈ $1.11 Billion |
-- |
About GREENLIGHT CAP.RE A DL-01
Greenlight Capital Re, Ltd., through its subsidiaries, operates as a property and casualty reinsurance company worldwide. It operates through Open Market and Innovations segments. The company offers casualty reinsurance, such as automobile liability and general liability. It also provides coverages for casualty, including general liability, umbrella, multiline casualty, and workers' compensation;… Read more